Enrofloxacin supplier | CasNO.93106-60-6

Name
Enrofloxacin
EINECS 618-911-2
CAS No. 93106-60-6
Article Data17
CAS DataBase
Density 1.385 g/cm³
Solubility Soluble in chloroform. Slightly soluble in water. Also soluble in dilute KOH
Melting Point 225 °C
Formula C₁₉H₂₂FN₃O₃
Boiling Point 560.5 °C at 760 mmHg
Molecular Weight 359.4
Flash Point 292.8 °C
Transport Information
Appearance Pale yellow crystals
Safety 26-36/37
Risk Codes 36/37/38
Molecular Structure
Hazard Symbols Xi
Synonyms 1-Cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylicacid;Alsir;BAY-Vp 2674;Baytril;Biofloxavet;CFPQ;Enrocin;Enrofan;Enrogil;Enroxil;N-Ethylciprofloxacin;N'-Ethylciprofloxacin;3-Quinolinecarboxylicacid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-;
PSA 65.78000
LogP 2.31850

Synthetic route

: 5308-25-8
4-ethylpiperazine

: 86393-33-1
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
With nano iron oxide on ZrO2 coated sulfonic acid In water for 0.316667h; Solvent; Temperature; Reagent/catalyst; Reflux;	97%
at 150℃; for 0.416667h; Microwave irradiation;	93%
With aluminum tri-bromide In ethanol at 75℃; for 4h; Reagent/catalyst; Solvent; Temperature;	92%

: 1-cyclopropyl-6-fluoro-7-chloro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid sodium salt

: 5308-25-8
4-ethylpiperazine

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
With aluminum (III) chloride In i-Amyl alcohol at 140℃; for 8h; Temperature;	91.8%

: 131776-44-8
ditrimethylsilyl N-cyclopropyl-3-(4-ethyl-1-piperazinyl)anilinomethylenemalonate

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
	90%

: 5308-25-8
4-ethylpiperazine

: 86393-33-1
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid

A: 7-chloro-1-cyclopropyl-6-(4-ethyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

B: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
In water for 13h; Heating;	A n/a B 89%

...Expand

: 74-96-4
ethyl bromide

: 93107-08-5
ciprofloxacin hydrochloride

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
With N-ethyl-N,N-diisopropylamine; potassium iodide In water; acetonitrile at 20℃; for 12h;	70%

: 5308-25-8
4-ethylpiperazine

: 98349-24-7
ethyl 2,4,5-trifluorobenzoylacetate

: 4637-24-5
N,N-dimethyl-formamide dimethyl acetal

: 765-30-0
Cyclopropylamine

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Yield given. Multistep reaction;

...Expand

: 86483-51-4
ethyl 2,4-dichloro-5-fluoro-benzoyl-acetate

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 5 steps 1: acetic anhydride / 2 h / Heating 2: 92 percent / ethanol / 1 h / Ambient temperature 3: 90 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 4: 93 percent / conc. H2SO4 / H2O / 1.5 h / Heating 5: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 86483-53-6
3-Cyclopropylamino-2-(2,4-dichlor-5-fluorbenzoyl)acrylsaeure-ethylester

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 1: 90 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 2: 93 percent / conc. H2SO4 / H2O / 1.5 h / Heating 3: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 86483-54-7
ethyl 1-cyclopropyl-7-chloro-6-fluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylate

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: 93 percent / conc. H2SO4 / H2O / 1.5 h / Heating 2: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 86393-34-2
2,4-dichloro-5-fluorobenzoyl chloride

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: 62 percent / pyridine / dioxane / 1.) 2 h, room temperature, 2.) 1 h, 70 - 80 deg C. 2: 85 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 3: 92 percent / conc. H2SO4 / H2O; acetic acid / 1.5 h / Heating 4: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme
Multi-step reaction with 7 steps 1: Mg/ethanol, CCl4 / ethanol; toluene / 1.) 0 to -5 deg C, 2.) 12 h, room temperature 2: p-toluenesulfonic acid / H2O / 5 h / Heating 3: acetic anhydride / 2 h / Heating 4: 92 percent / ethanol / 1 h / Ambient temperature 5: 90 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 6: 93 percent / conc. H2SO4 / H2O / 1.5 h / Heating 7: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme
Multi-step reaction with 2 steps 1.1: tributyl-amine / 1 h / 70 °C 1.2: 15 °C / 1520.1 Torr 2.1: cesium hydroxide / 5,5-dimethyl-1,3-cyclohexadiene / 125 - 130 °C 2.2: 8 h / 85 °C View Scheme

: 105392-26-5
3-Cyclopropylamino-2-(2,4-dichlor-5-fluorbenzoyl)acrylsaeure-methylester

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 1: 85 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 2: 92 percent / conc. H2SO4 / H2O; acetic acid / 1.5 h / Heating 3: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 104599-90-8
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid methyl ester

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: 92 percent / conc. H2SO4 / H2O; acetic acid / 1.5 h / Heating 2: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 86483-50-3
diethyl 2,4-dichloro-5-fluoro-benzoyl-malonate

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 6 steps 1: p-toluenesulfonic acid / H2O / 5 h / Heating 2: acetic anhydride / 2 h / Heating 3: 92 percent / ethanol / 1 h / Ambient temperature 4: 90 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 5: 93 percent / conc. H2SO4 / H2O / 1.5 h / Heating 6: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 72396-25-9
3-(Cyclopropylamino)acrylsaeure-methylester

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: 62 percent / pyridine / dioxane / 1.) 2 h, room temperature, 2.) 1 h, 70 - 80 deg C. 2: 85 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 3: 92 percent / conc. H2SO4 / H2O; acetic acid / 1.5 h / Heating 4: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 86483-52-5
2,4-dichloro-alpha(elhoxymethlene)-5-fluoro-beta-oxo-benzene propanoic acid ethyl ester

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Multi-step reaction with 4 steps 1: 92 percent / ethanol / 1 h / Ambient temperature 2: 90 percent / potassium carbonate / dimethylformamide / 2 h / 140 - 150 °C 3: 93 percent / conc. H2SO4 / H2O / 1.5 h / Heating 4: 86 percent / dimethylsulfoxide / 2.5 h / 140 °C View Scheme

: 5308-25-8
4-ethylpiperazine

: 86483-53-6
3-Cyclopropylamino-2-(2,4-dichlor-5-fluorbenzoyl)acrylsaeure-ethylester

: 93106-60-6
enrofloxacin

Conditions

Conditions	Yield
Stage #1: 3-Cyclopropylamino-2-(2,4-dichlor-5-fluorbenzoyl)acrylsaeure-ethylester With cesium hydroxide In 5,5-dimethyl-1,3-cyclohexadiene at 125 - 130℃; Stage #2: 4-ethylpiperazine With aluminum (III) chloride In ethanol at 85℃; for 8h; Solvent; Reagent/catalyst; Temperature;	48.7 g

: 93106-60-6
enrofloxacin

: 474022-78-1
1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-quinolinoyl chloride

Conditions

Conditions	Yield
With thionyl chloride for 10h; Heating;	95.1%
With thionyl chloride at 75℃; for 10h;
With thionyl chloride at 70℃;

: C6H16Cl4Cu2N8O2

: 93106-60-6
enrofloxacin

: C22H29CuFN7O4(1+)*Cl(1-)

Conditions

Conditions	Yield
With sodium hydroxide In methanol at 20℃; for 2h;	88%

: 93106-60-6
enrofloxacin

: 530-62-1
1,1'-carbonyldiimidazole

: 1-cyclopropyl-6-fluoro-7-(4-ethylpiperazin-1-yl)-3-(1H-imidazole-1-formyl)-quinoline-4(1H)-one

Conditions

Conditions	Yield
In acetonitrile Solvent; Reflux;	86.4%

: 93106-60-6
enrofloxacin

: C38H50CaF2N6O10

Conditions

Conditions	Yield
With water; calcium hydroxide In methanol at 40℃; for 8h; Temperature; Solvent;	85%

: 66-71-7
1,10-Phenanthroline

: nickel(II) chloride hexahydrate

: 93106-60-6
enrofloxacin

: [Ni(enx)2(1,10-phenantroline)]

Conditions

Conditions	Yield
With hydrogenchloride; potassium hydroxide In ethanol for 2h; pH=7;	85%

...Expand

: 66-71-7
1,10-Phenanthroline

: cobalt(II) chloride hexahydrate

: 93106-60-6
enrofloxacin

: [Co(enx)2(1,10-phenantroline)]

Conditions

Conditions	Yield
With hydrogenchloride; potassium hydroxide In ethanol for 2h; pH=7;	82%

...Expand

: 148-24-3
8-quinolinol

: nickel(II) chloride hexahydrate

: 93106-60-6
enrofloxacin

: [Ni(enx)2(1,10-phenantroline)(Q)]

Conditions

Conditions	Yield
With hydrogenchloride; potassium hydroxide In ethanol for 2h; pH=7; Reflux;	80%

...Expand

: 148-24-3
8-quinolinol

: cobalt(II) chloride hexahydrate

: 93106-60-6
enrofloxacin

: C28H27CoFN4O4*H2O

Conditions

Conditions	Yield
With hydrogenchloride; potassium hydroxide In ethanol for 1h; pH=7; Reflux;	80%

...Expand

: 148-24-3
8-quinolinol

: nickel(II) chloride hexahydrate

: 93106-60-6
enrofloxacin

: C28H27FN4NiO4*H2O

Conditions

Conditions	Yield
With hydrogenchloride; potassium hydroxide In ethanol for 1h; pH=7; Reflux;	78%

...Expand

: 7727-18-6
vanadium(V) oxychloride

: 93106-60-6
enrofloxacin

: 95-53-4
o-toluidine

: bis[1-cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylato]4-(4-amino-3-methylphenyl)-2-methylanilineoxo vanadium chloride monohydrate

Conditions

Conditions	Yield
Stage #1: vanadium(V) oxychloride; enrofloxacin With sodium hydroxide In ethanol at 20℃; for 1h; Stage #2: o-toluidine In ethanol at 20℃; for 72h;	77%

...Expand

: zinc(II) perchlorate

: 93106-60-6
enrofloxacin

: C57H63F3N9O9Zn(1-)

Conditions

Conditions	Yield
With ammonium hydroxide In methanol; water for 0.166667h;	77%

: 95-14-7
1,2,3-Benzotriazole

: 93106-60-6
enrofloxacin

: 1381763-39-8
3-(1H-benzo[d][1,2,3]triazole-1-carbonyl)-1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoroquinolin-4(1H)-one

Conditions

Conditions	Yield
With thionyl chloride In dichloromethane at 20℃;	76%

: 93106-60-6
enrofloxacin

: 75-31-0
isopropylamine

: 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-1,4-dihydro-4-oxo-N-(propan-2-yl)quinoline-3-carboxamide

Conditions

Conditions	Yield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃;	76%

: 7727-18-6
vanadium(V) oxychloride

: 93106-60-6
enrofloxacin

: 121-44-8
triethylamine

: bis[1-cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylato]N,N-diethylethanamineoxo vanadium chloride hexahydrate

Conditions

Conditions	Yield
Stage #1: vanadium(V) oxychloride; enrofloxacin With sodium hydroxide In ethanol at 20℃; for 1h; Stage #2: triethylamine In ethanol at 20℃; for 72h;	76%

...Expand

: bis(acetylacetonato)dioxidomolybdenum(VI)

: 93106-60-6
enrofloxacin

: MoO2(1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate)2

Conditions

Conditions	Yield
With potassium hydroxide In methanol a MeOH soln. of 2 equiv. of F-compd. deprotonated with 2 equiv. of KOH was added to the Mo-compd. soln. in MeOH, reflux for 2.5 h; soln. was filtered and left to slowly evaporate for a few days, crystalswere filtered off, washed with MeOH and dried, elem. anal.;	75%

: manganese(II) chloride tetrahydrate

: 93106-60-6
enrofloxacin

: 1030834-09-3
Mn(1-cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylato)2(H2O)2

Conditions

Conditions	Yield
With potassium hydroxide In methanol a soln. of ligand deprotonated with KOH, added to a soln. of Mn salt, refluxed for 2 h; filtered, crystd. for days, filtered, washed (MeOH), dried; elem. anal.;	75%

: zinc(II) nitrate hexahydrate

: (4S)-4-isopropyl-N-[(4R)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]-N-(4-vinylbenzyl)-4,5-dihydro-1,3-oxazol-2-amine

: 7732-18-5
water

: 93106-60-6
enrofloxacin

: C40H50FN6O5Zn(1+)*NO3(1-)

Conditions

Conditions	Yield
With sodium hydroxide In acetonitrile	75%

...Expand

: C20H28Cl4Cu2N8O2

: 93106-60-6
enrofloxacin

: C29H35CuFN7O4(1+)*Cl(1-)

Conditions

Conditions	Yield
With sodium hydroxide In methanol at 20℃; for 2h;	74.1%

: 7727-18-6
vanadium(V) oxychloride

: 93106-60-6
enrofloxacin

: 68-12-2, 33513-42-7
N,N-dimethyl-formamide

: bis[1-cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylato]N,N-dimethylformamideoxo vanadium chloride pentahydrate

Conditions

Conditions	Yield
Stage #1: vanadium(V) oxychloride; enrofloxacin With sodium hydroxide In ethanol at 20℃; for 1h; Stage #2: N,N-dimethyl-formamide In ethanol at 20℃; for 72h;	74%

...Expand

: 110-86-1
pyridine

: 7727-18-6
vanadium(V) oxychloride

: 93106-60-6
enrofloxacin

: bis[1-cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylato]pyridineoxo vanadium chloride tetrahydrate

Conditions

Conditions	Yield
Stage #1: vanadium(V) oxychloride; enrofloxacin With sodium hydroxide In ethanol at 20℃; for 1h; Stage #2: pyridine In ethanol at 20℃; for 72h;	73%

...Expand

: 109-63-7
boron trifluoride diethyl etherate

: 93106-60-6
enrofloxacin

: difluoroboron complexes of enrofloxacin

Conditions

Conditions	Yield
In dichloromethane; N,N-dimethyl-formamide for 24h; Reflux;	71%

: cobalt(II) chloride hexahydrate

: 93106-60-6
enrofloxacin

: 1030834-12-8
Co(1-cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylato)2(H2O)2

Conditions

Conditions	Yield
With potassium hydroxide In methanol a soln. of ligand deprotonated with KOH, added to a soln. of Co salt, refluxed; filtered, crystd., filtered, washed (MeOH), dried; elem. anal.;	70%

: 110-86-1
pyridine

: 67-56-1
methanol

: 7732-18-5
water

: 93106-60-6
enrofloxacin

: 7646-85-7
zinc(II) chloride

: bis(enrofloxacinato)bis(pyridine)zinc(II) hexahydrate monomethanolate

Conditions

Conditions	Yield
With KOH In methanol KOH added to MeOH soln. of enrofloxacin; added to MeOH soln. of ZnCl2; pyridine added; crystd. by slow evapn. after 10 d; elem. anal.;	70%

...Expand

: 366-18-7
[2,2]bipyridinyl

: 93106-60-6
enrofloxacin

: 7646-85-7
zinc(II) chloride

: 1426910-55-5
[Zn(erx)(bipy)Cl]

Conditions

Conditions	Yield
Stage #1: enrofloxacin With potassium hydroxide In methanol at 20℃; for 0.333333h; Stage #2: [2,2]bipyridinyl; zinc(II) chloride In methanol	70%

...Expand

: 67-56-1
methanol

: 66-71-7
1,10-Phenanthroline

: manganese(II) chloride tetrahydrate

: 93106-60-6
enrofloxacin

: [Mn(enrofloxacinato)2(1,10-phenanthroline)]*1.5MeOH*H2O

Conditions

Conditions	Yield
Stage #1: methanol; enrofloxacin With potassium hydroxide for 0.5h; Stage #2: methanol; 1,10-Phenanthroline; manganese(II) chloride tetrahydrate for 1h;	70%

...Expand

Enrofloxacin Chemical Properties

IUPAC Name: 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
Molecular Weight: 359.394683 [g/mol]
Molecular Formula: C₁₉H₂₂FN₃O₃
XLogP3: -0.2
H-Bond Donor: 1
H-Bond Acceptor: 7
Index of Refraction: 1.634
Molar Refractivity: 92.8 cm³
Molar Volume: 259.3 cm³
Surface Tension: 62 dyne/cm
Density: 1.385 g/cm³
Flash Point: 292.8 °C
Enthalpy of Vaporization: 88.7 kJ/mol
Boiling Point: 560.5 °C at 760 mmHg
Vapour Pressure: 2.13E-13 mmHg at 25 °C
Water Solubility: 3400 mg/L at 25 °C
Appearance: Pale Yellow Crystals
Melting Point: 225 °C
Classification Code of Enrofloxacin (CAS NO.93106-60-6): Antibacterial [veterinary]; Antineoplastic agents; Drug / Therapeutic Agent; Mutation data
Product Categories: Antibiotics for Research and Experimental Use; Biochemistry; Quinolones (Antibiotics for Research and Experimental Use); Intermediates & Fine Chemicals; Pharmaceuticals; Veterinaries

Enrofloxacin Uses

Enrofloxacin (CAS NO.93106-60-6) is widely used in the treatment of human disease. It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration dependent, with susceptible bacteria cell death occurring within 20-30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication.

Enrofloxacin Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Source
mouse	LD50	intravenous	200mg/kg (200mg/kg)	VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.
mouse	LD50	oral	4336mg/kg (4336mg/kg)	VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.
rabbit	LD50	oral	500mg/kg (500mg/kg)	VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.
rat	LD50	oral	5gm/kg (5000mg/kg)	VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.

Enrofloxacin Safety Profile

Hazard Codes: Irritant Xi
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36/37
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37:Wear suitable protective clothing and gloves.
WGK Germany: 3
RTECS of Enrofloxacin (CAS NO.93106-60-6): VB1993650

Enrofloxacin Specification

Enrofloxacin (CAS NO.93106-60-6), its Synonyms are 1,4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid ; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid ; BAY VP 2674 ; Enrofloxacine ; Enrofloxacino ; 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo- ; 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo- .

Product Name

Enrofloxacin

Synthetic route

Enrofloxacin Chemical Properties

Enrofloxacin Uses

Enrofloxacin Toxicity Data With Reference

Enrofloxacin Safety Profile

Enrofloxacin Specification

Related Products

Hot Products